CSCO 10th Hematologic Malignancies Congress | Director Yajing Zhang: Moving Beyond “Target-Centric” Thinking to Redefine Lifelong Management of Hematologic Malignancies Through a Systems-Based Approach

CSCO 10th Hematologic Malignancies Congress | Director Yajing Zhang: Moving Beyond “Target-Centric” Thinking to Redefine Lifelong Management of Hematologic Malignancies Through a Systems-Based Approach

From July 10–12, 2026, the 10th Hematologic Malignancies Congress of the Chinese Society of Clinical Oncology (CSCO) was held in Harbin, China. Over the past decade, the meeting has grown into one of China's premier academic forums for hematologic oncology. This year's congress not only celebrated ten years of scientific achievement but also marked an important milestone for future innovation.
EHA Conversations | Director Zhihui Li & Professor Yi Lin: Advancing CAR-T Manufacturing Through Innovation and Process Optimization

EHA Conversations | Director Zhihui Li & Professor Yi Lin: Advancing CAR-T Manufacturing Through Innovation and Process Optimization

Bridging expertise across continents to explore the future of cellular therapy, Oncology Frontier – Hematology Frontier hosted an in-depth conversation during the 2026 European Hematology Association (EHA) Congress featuring Director Zhihui Li of Beijing GoBroad Boren Hospital and Professor Yi Lin of the Mayo Clinic. Centered on the theme "CAR-T Manufacturing: Scientific Advances and Technological Innovation," the discussion examined key developments shaping the next generation of CAR-T therapy, including rapid manufacturing platforms, in vivo CAR-T technologies, novel CAR molecular designs, and the emerging issue of secondary malignancies. Together, the two experts outlined a compelling vision for improving CAR-T manufacturing, enhancing safety, and accelerating clinical translation.
CUDA 2026 | Professor Xuepei Zhang: Advancing High-Quality Urologic Care and Regional Collaboration from Zhengzhou

CUDA 2026 | Professor Xuepei Zhang: Advancing High-Quality Urologic Care and Regional Collaboration from Zhengzhou

From June 11–14, 2026, the 2026 Annual Meeting of the Chinese Urological Association of the Chinese Medical Doctor Association (CUDA) was held in Zhengzhou, Henan Province. The meeting was hosted by the Chinese Medical Doctor Association (CMDA) and the Chinese Urological Association of the CMDA (CUDA), and jointly organized by The First Affiliated Hospital of Zhengzhou University, Henan Provincial People's Hospital, and The First Affiliated Hospital of Henan University, with additional support from Henan Cancer Hospital, The First Affiliated Hospital of Henan University of Chinese Medicine, and The Second Affiliated Hospital of Zhengzhou University.
CUDA 2026 | Professor Lianqu Wang: Leveraging a Century of Medical Education and Regional Healthcare Strengths to Advance Integrated Clinical Care, Education, and Research in Urology at Henan University

CUDA 2026 | Professor Lianqu Wang: Leveraging a Century of Medical Education and Regional Healthcare Strengths to Advance Integrated Clinical Care, Education, and Research in Urology at Henan University

Hosted by the Chinese Medical Doctor Association (CMDA) and the Chinese Urological Association of the CMDA (CUDA), the 2026 CUDA Annual Meeting was held in Zhengzhou, Henan Province, from June 11–14, 2026. The meeting was jointly organized by The First Affiliated Hospital of Zhengzhou University, Henan Provincial People's Hospital, and The First Affiliated Hospital of Henan University, with additional support from Henan Cancer Hospital, The First Affiliated Hospital of Henan University of Chinese Medicine, and The Second Affiliated Hospital of Zhengzhou University.
CUDA 2026 | Professor Linhui Wang: Advancing Precision Kidney-Sparing Surgery in the Modern Era of Renal Cancer Care

CUDA 2026 | Professor Linhui Wang: Advancing Precision Kidney-Sparing Surgery in the Modern Era of Renal Cancer Care

Hosted by the Chinese Medical Doctor Association (CMDA) and the Chinese Urological Association of the CMDA (CUDA), the 2026 CUDA Annual Meeting was held in Zhengzhou, Henan Province, from June 11–14, 2026. Continuing the discipline's mission of "Healthy China, Urology at the Forefront," this year's conference was themed "Collaboration and Innovation for Future Development." The scientific program featured in-depth discussions on precision surgery, advances in minimally invasive techniques, and the evolving role of robotic surgery through expert lectures, live surgical demonstrations, and multidisciplinary forums.
Professor Benlong Yang: Breast Surgery Enters the Era of De-escalation and Individualized Care in Precision Oncology | 2026 CACA Cancer Prevention and Screening Conference

Professor Benlong Yang: Breast Surgery Enters the Era of De-escalation and Individualized Care in Precision Oncology | 2026 CACA Cancer Prevention and Screening Conference

The 2026 CACA Cancer Prevention and Screening Conference recently opened in Hangzhou, bringing together leading oncologists, researchers, and industry experts from across China to discuss advances in cancer prevention, early detection, multidisciplinary collaboration, and translational research. Hosted by the Chinese Anti-Cancer Association (CACA) and its Cancer Prevention and Screening Committee, the meeting aligns with the goals of the Healthy China 2030 initiative by promoting earlier intervention throughout the cancer care continuum.
2026 Lingnan Breast Cancer Forum | Ciqiu Yang: Precision Decision-Making for Breast-Conserving Surgery and Axillary Preservation After Neoadjuvant Therapy

2026 Lingnan Breast Cancer Forum | Ciqiu Yang: Precision Decision-Making for Breast-Conserving Surgery and Axillary Preservation After Neoadjuvant Therapy

Neoadjuvant therapy has created new opportunities for breast-conserving surgery and axillary preservation in patients with breast cancer. However, accurately defining the extent of surgery after neoadjuvant treatment and determining the optimal management of axillary lymph nodes remain among the most important and challenging issues in contemporary breast cancer care.
2026 Lingnan Breast Cancer Forum | Professor Kun Wang: Advancing Integrated Prevention and Care Across the Entire Breast Cancer Journey

2026 Lingnan Breast Cancer Forum | Professor Kun Wang: Advancing Integrated Prevention and Care Across the Entire Breast Cancer Journey

The 2026 Lingnan Breast Cancer Forum was recently held in Guangzhou, bringing together breast cancer specialists from across China to discuss the latest advances in prevention, diagnosis, treatment, and survivorship. Centered on the concept of whole-course breast cancer management, the meeting integrated the year's most important international breakthroughs with a comprehensive scientific program covering early detection, precision diagnosis, individualized treatment, innovative therapies, and postoperative rehabilitation.